Erle T. Mast, Executive VP and CFO at Clovis Oncology, Inc. (CLVS), sold 9,000 shares at $79.56 ($710K) on 2015-03-09, disclosed to the SEC on 2015-03-11.
Scheduled sale ($710k) by Executive VP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.78 | 8,400 | $662K | 93.3% |
| 2 | $79.56 | 500 | $40K | 5.6% |
| 3 | $80.40 | 100 | $8K | 1.1% |
| Total | $78.84 avg | 9,000 | $710K | 100% |
| Filing → |
| SNNA | BUY | 2017-08-01 | $101K | — | Filing → |
| CLVS | SELL | 2015-11-03 | $317K | — | Filing → |
| CLVS | SELL | 2015-10-02 | $271K | — | Filing → |